Schlusskurs
Andere Börsenplätze
|
||
- USD | - |
Kurzporträt
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Edward Chiang
FOU | Founder | - | 01.09.11 |
William Sibold
CEO | Chief Executive Officer | 57 | 08.09.23 |
Rebecca Taub
FOU | Founder | 71 | 01.07.16 |
Ronald Filippo
CTO | Chief Tech/Sci/R&D Officer | - | 21.11. |
Stephen Dodge
CTO | Chief Tech/Sci/R&D Officer | - | - |
Paul Friedman
BRD | Director/Board Member | 81 | 22.07.16 |
Tina Ventura
IRC | Investor Relations Contact | - | 29.01. |
Carole Huntsman
PRN | Corporate Officer/Principal | 59 | - |
Corporate Officer/Principal | - | 10.01.22 | |
Corporate Officer/Principal | 61 | 02.08.21 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Fred Craves
FOU | Founder | 78 | 01.09.11 |
Julian Baker
CHM | Chairman | 57 | 15.06.23 |
Ken Bate
BRD | Director/Board Member | 73 | 22.07.16 |
Paul Friedman
BRD | Director/Board Member | 81 | 22.07.16 |
Richard Levy
BRD | Director/Board Member | 66 | 11.08.16 |
Rebecca Taub
FOU | Founder | 71 | 01.07.16 |
William Sibold
CEO | Chief Executive Officer | 57 | 08.09.23 |
James Daly
BRD | Director/Board Member | 62 | 27.06.19 |
Raymond Cheong
BRD | Director/Board Member | 42 | 15.06.23 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 21 311 526 | 17 648 651 ( 82,81 %) | 0 | 82,81 % |
Unternehmenskontakt
Madrigal Pharmaceuticals, Inc.
200 Barr Harbor Drive Suite 200
19428, West Conshohocken
+267 824 2827
http://www.madrigalpharma.comSektor
% 1. Jan. | Kap. | |
---|---|---|
+15.82% | 121 Mrd. | |
+20.35% | 113 Mrd. | |
+17.47% | 26.02 Mrd. | |
-25.31% | 19.39 Mrd. | |
-19.51% | 15.91 Mrd. | |
-19.67% | 15.09 Mrd. | |
-46.87% | 15.06 Mrd. | |
+62.55% | 14.93 Mrd. | |
+6.34% | 13.85 Mrd. |
- Börse
- Aktien
- A2APCZ Aktie
- Aktie
- Unternehmen Synta Pharmaceuticals Corp.